Melanoma Evidence & Self-Care · education / decision-support

← Evidence library

BIB_053

Larkin J, Chiarion-Sileni V, Gonzalez R, et al. Combined Nivolumab and Ipilimumab in Untreated Advanced Melanoma. NEJM 2015;373(1):23–34. PMID 26027431. CheckMate-067; long-term follow-up Wolchok 2017, 2022 → mOS 72 mo. [Tasks: L, 18] Tier: 2 Grade: A Retrieved: 2026-05-06

Evidence grade
A
Tier
2
Cited by tasks
L, 18
Identifiers
PMID:26027431

↗ Follow the original source for full context

Full extracted findings & patient-implication analysis: bibliography/BIB_053/findings.md (research corpus). This page is a short context summary — not individualised medical advice.